What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Disease
His primary scientific interests are in COPD, Internal medicine, Physical therapy, Surgery and Spirometry.
His study in COPD focuses on Obstructive lung disease in particular.
His study in Internal medicine is interdisciplinary in nature, drawing from both Placebo and Cardiology.
While the research belongs to areas of Physical therapy, Bartolome R. Celli spends his time largely on the problem of Comorbidity, intersecting his research to questions surrounding Heart failure.
His research investigates the link between Surgery and topics such as Pulmonary function testing that cross with problems in Airway obstruction.
The study incorporates disciplines such as Vital capacity, FEV1/FVC ratio and C-reactive protein in addition to Spirometry.
His most cited work include:
- Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper (3605 citations)
- Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (3310 citations)
- The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease (3030 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in COPD, Internal medicine, Physical therapy, Intensive care medicine and Cardiology.
His COPD study combines topics in areas such as Pulmonary disease, Exacerbation, Spirometry and Disease.
His Internal medicine study incorporates themes from Placebo and Surgery.
His Placebo research is multidisciplinary, incorporating elements of Randomized controlled trial and Fluticasone propionate.
His biological study spans a wide range of topics, including Anesthesia, Respiratory disease and Lung volumes.
The concepts of his Physical therapy study are interwoven with issues in Obstructive lung disease, Prospective cohort study, Quality of life and Severity of illness.
He most often published in these fields:
- COPD (64.79%)
- Internal medicine (48.82%)
- Physical therapy (22.77%)
What were the highlights of his more recent work (between 2017-2021)?
- COPD (64.79%)
- Internal medicine (48.82%)
- Pulmonary disease (17.54%)
In recent papers he was focusing on the following fields of study:
Bartolome R. Celli mostly deals with COPD, Internal medicine, Pulmonary disease, Intensive care medicine and MEDLINE.
In general COPD study, his work on BODE index often relates to the realm of In patient, thereby connecting several areas of interest.
His Internal medicine research includes elements of Placebo and Cardiology.
His Pulmonary disease study deals with Immunology intersecting with Endothelial dysfunction, Vasodilation and Prostacyclin.
His Intensive care medicine study integrates concerns from other disciplines, such as Precision medicine, Respiratory failure, Meta-analysis, Global health and Spirometry.
Bartolome R. Celli has included themes like Phenotype, Disease progression and Incidence in his MEDLINE study.
Between 2017 and 2021, his most popular works were:
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019 (472 citations)
- At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease. (71 citations)
- Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial. (70 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
His main research concerns COPD, Internal medicine, Pulmonary disease, Intensive care medicine and Disease.
Bartolome R. Celli performs multidisciplinary study in the fields of COPD and In patient via his papers.
His studies deal with areas such as Placebo and Cardiology as well as Internal medicine.
The various areas that Bartolome R. Celli examines in his Pulmonary disease study include Cigarette smoking, Soft mist inhaler, Respimat, Lung function and MEDLINE.
He studied Intensive care medicine and Precision medicine that intersect with Obstructive lung disease and Therapeutic effect.
His Genetic predisposition study, which is part of a larger body of work in Disease, is frequently linked to Unmet needs, bridging the gap between disciplines.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
